MedPath
FDA Product

Eszopiclone

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Eszopiclone

68462-383

Regulatory Information

68462-383

ANDA091166

C73584

October 18, 2019

USA

These highlights do not include all the information needed to use ESZOPICLONE TABLETS safely and effectively. See full prescribing information for ESZOPICLONE TABLETS. ESZOPICLONE Tablets, for oral use, CIVInitial U.S. Approval: 2004

HUMAN PRESCRIPTION DRUG LABEL

10

Company Information

130597813

Active Ingredients

ANHYDROUS LACTOSE

Code: 3SY5LH9PMK

Class Code: IACT

ESZOPICLONE

Quantity: 2 mg in 1 1

Code: UZX80K71OE

Class Code: ACTIB

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Code: L11K75P92J

Class Code: IACT

CROSCARMELLOSE SODIUM

Code: M28OL1HH48

Class Code: IACT

HYPROMELLOSE, UNSPECIFIED

Code: 3NXW29V3WO

Class Code: IACT

LACTOSE MONOHYDRATE

Code: EWQ57Q8I5X

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

POLYETHYLENE GLYCOL, UNSPECIFIED

Code: 3WJQ0SDW1A

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

TRIACETIN

Code: XHX3C3X673

Class Code: IACT

Active Moieties

ESZOPICLONE

Code: UZX80K71OE

© Copyright 2025. All Rights Reserved by MedPath